Main menu button

News

Equity research Zinzino Q2, 2025: Expansion costs hamper margins, but strong outlook
29 aug 2025
Equity research Zinzino Q2, 2025: Expansion costs hamper margins, but strong outlook
Equity Research Zinzino
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
28 aug 2025
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
Equity Research Immunovia
Equity Research Svenska Aerogel, Q2 2025: Strong growth, but lower than expected revenues
28 aug 2025
Equity Research Svenska Aerogel, Q2 2025: Strong growth, but lower than expected revenues
Equity Research Svenska Aerogel
Equity research Viva Wine Group Q2, 2025: Stable performance in a soft market
28 aug 2025
Equity research Viva Wine Group Q2, 2025: Stable performance in a soft market
Equity Research Viva Wine Group
Equity research Nosa Plugs Q2, 2025: Growth ahead but mixed results in Q2
27 aug 2025
Equity research Nosa Plugs Q2, 2025: Growth ahead but mixed results in Q2
Equity Research Nosa Plugs
Analys Elicera Therapeutics: Låg dos tillräckligt för att eliminera aktivt lymfom i fyra av sex patienter
25 aug 2025
Analys Elicera Therapeutics: Låg dos tillräckligt för att eliminera aktivt lymfom i fyra av sex patienter
Equity Research Elicera Therapeutics
Equity research, White Pearl Technology Group: A hidden gem among the tech companies
21 aug 2025
Equity research, White Pearl Technology Group: A hidden gem among the tech companies
Equity Research White Pearl Technology Group
Carlsquare Global Tech Summit 2025
20 aug 2025
Carlsquare Global Tech Summit 2025
Events
Equity Research KlaraBo: The option programme demonstrates a strong commitment
19 aug 2025
Equity Research KlaraBo: The option programme demonstrates a strong commitment
Equity Research KlaraBo
Carlsquare advised Boomi on the acquisition of Thru
14 aug 2025
Carlsquare advised Boomi on the acquisition of Thru
Deal News
Equity Research Svenska Aerogel: Financing secured through directed issues of units
13 aug 2025
Equity Research Svenska Aerogel: Financing secured through directed issues of units
Equity Research Svenska Aerogel
Equity research Viva Wine Group, Q2 2025: No market tailwind but support from Delta acquisition
11 aug 2025
Equity research Viva Wine Group, Q2 2025: No market tailwind but support from Delta acquisition
Equity Research Viva Wine Group
Carlsquare advises Afinum Management on €75m sale of Kappa optronics to Theon International Plc (AMS: THEON)
06 aug 2025
Carlsquare advises Afinum Management on €75m sale of Kappa optronics to Theon International Plc (AMS: THEON)
Deal News
Equity research, Candles Scandinavia: Unlocking shareholder value through a sizable strategic acquisition
25 jul 2025
Equity research, Candles Scandinavia: Unlocking shareholder value through a sizable strategic acquisition
Equity Research Candles Scandinavia
Equity Research ALM Equity Q2 2025: More housing starts are needed
21 jul 2025
Equity Research ALM Equity Q2 2025: More housing starts are needed
Equity Research ALM Equity
Equity Research KlaraBo, Q2 2025: Focus on renovation and acquisitions
18 jul 2025
Equity Research KlaraBo, Q2 2025: Focus on renovation and acquisitions
Equity Research KlaraBo
Carlsquare advised the exiting founding shareholder in the reorganisation of the Bihl+Wiedemann shareholder structure
17 jul 2025
Carlsquare advised the exiting founding shareholder in the reorganisation of the Bihl+Wiedemann shareholder structure
Deal News
Equity Research KlaraBo, Q2 2025: Good momentum in the renovation of apartments
17 jul 2025
Equity Research KlaraBo, Q2 2025: Good momentum in the renovation of apartments
Equity Research KlaraBo
Equity Research ALM Equity, Q2 2025: The turnaround delayed until the end of 2025
17 jul 2025
Equity Research ALM Equity, Q2 2025: The turnaround delayed until the end of 2025
Equity Research ALM Equity
Equity research CDON Q2 2025: Back to growth sooner than expected
16 jul 2025
Equity research CDON Q2 2025: Back to growth sooner than expected
Equity Research CDON